.Pharmacolibrary.Drugs.ATC.N.N02CC04

Information

name:Rizatriptan
ATC code:N02CC04
route:oral
n-compartments1

Rizatriptan is a selective serotonin 5-HT1B/1D receptor agonist (triptan class) used in the acute treatment of migraine attacks with or without aura in adults. It is approved and widely used today for this indication.

Pharmacokinetics

Healthy adult subjects, single-dose pharmacokinetics after oral administration.

References

  1. Tellone, V, et al., & Wedemeyer, RS (2020). A novel rizatriptan oral gel formulation: Bioavailability and bioequivalence. International journal of clinical pharmacology and therapeutics 58(10) 583–594. DOI:10.5414/CP203652 PUBMED:https://pubmed.ncbi.nlm.nih.gov/32716291

  2. Fraser, IP, et al., & Winner, P (2012). Pharmacokinetics and tolerability of rizatriptan in pediatric migraineurs in a randomized study. Headache 52(4) 625–635. DOI:10.1111/j.1526-4610.2011.02069.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/22289113

  3. Eiland, LS, & Hunt, MO (2010). The use of triptans for pediatric migraines. Paediatric drugs 12(6) 379–389. DOI:10.2165/11532860-000000000-00000 PUBMED:https://pubmed.ncbi.nlm.nih.gov/21028917

Revisions

Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos